Presentation TCT 2017 Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities? Presenter: Larry L. Wood October 31, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Aortic Valve Up Next Presentation TCT 2017 Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences Presenter: Martin B. Leon October 31, 2017 More slides + Presentation TCT 2017 Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance Presenter: Lars Sondergaard October 31, 2017 Presentation TCT 2017 FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices Presenter: John C Laschinger October 31, 2017 We Recommend
Presentation TCT 2017 Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences Presenter: Martin B. Leon October 31, 2017
Presentation TCT 2017 Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance Presenter: Lars Sondergaard October 31, 2017
Presentation TCT 2017 FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices Presenter: John C Laschinger October 31, 2017